Robert O'Hare, the Chief Financial Officer of $AFRM, sold 77,800 shares of the company on 08-22-2025 for an estimated $6,231,002. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $AFRM stock.
$AFRM Insider Trading Activity
$AFRM insiders have traded $AFRM stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $AFRM stock by insiders over the last 6 months:
- MICHAEL LINFORD (Chief Operating Officer) has made 0 purchases and 2 sales selling 195,000 shares for an estimated $15,616,578.
- MAX R LEVCHIN (Chief Executive Officer) has made 0 purchases and 2 sales selling 182,396 shares for an estimated $14,609,171.
- KATHERINE ADKINS (Chief Legal Officer) has made 0 purchases and 4 sales selling 124,187 shares for an estimated $9,045,117.
- ROBERT O'HARE (Chief Financial Officer) has made 0 purchases and 3 sales selling 109,007 shares for an estimated $8,530,136.
- KEITH RABOIS has made 0 purchases and 11 sales selling 48,265 shares for an estimated $2,580,200.
- SIPHELELE JIYANE (Chief Accounting Officer) sold 15,871 shares for an estimated $1,190,325
- NOEL BERTRAM WATSON has made 0 purchases and 7 sales selling 5,000 shares for an estimated $266,597.
- CHRISTA S QUARLES sold 754 shares for an estimated $50,842
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AFRM Hedge Fund Activity
We have seen 337 institutional investors add shares of $AFRM stock to their portfolio, and 276 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COATUE MANAGEMENT LLC removed 2,633,442 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $119,005,243
- CITADEL ADVISORS LLC removed 2,526,577 shares (-94.4%) from their portfolio in Q2 2025, for an estimated $174,687,533
- BLACKROCK, INC. added 2,423,821 shares (+18.3%) to their portfolio in Q2 2025, for an estimated $167,582,983
- ATREIDES MANAGEMENT, LP added 1,670,429 shares (+543.3%) to their portfolio in Q2 2025, for an estimated $115,493,461
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,644,545 shares (-56.4%) from their portfolio in Q2 2025, for an estimated $113,703,841
- HOLOCENE ADVISORS, LP removed 1,595,879 shares (-63.9%) from their portfolio in Q2 2025, for an estimated $110,339,074
- BAILLIE GIFFORD & CO removed 1,471,061 shares (-16.3%) from their portfolio in Q2 2025, for an estimated $101,709,157
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AFRM Analyst Ratings
Wall Street analysts have issued reports on $AFRM in the last several months. We have seen 14 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 08/20/2025
- Susquehanna issued a "Positive" rating on 07/23/2025
- Oppenheimer issued a "Outperform" rating on 07/21/2025
- Truist Securities issued a "Buy" rating on 07/17/2025
- Deutsche Bank issued a "Buy" rating on 07/17/2025
- Barclays issued a "Overweight" rating on 06/30/2025
- Goldman Sachs issued a "Buy" rating on 05/12/2025
To track analyst ratings and price targets for $AFRM, check out Quiver Quantitative's $AFRM forecast page.
$AFRM Price Targets
Multiple analysts have issued price targets for $AFRM recently. We have seen 17 analysts offer price targets for $AFRM in the last 6 months, with a median target of $72.0.
Here are some recent targets:
- Reginald Smith from JP Morgan set a target price of $91.0 on 08/20/2025
- James Friedman from Susquehanna set a target price of $76.0 on 07/23/2025
- Matthew Coad from Truist Securities set a target price of $72.0 on 07/22/2025
- Rayna Kumar from Oppenheimer set a target price of $80.0 on 07/21/2025
- Bryan Keane from Deutsche Bank set a target price of $78.0 on 07/17/2025
- Daniel Perlin from RBC Capital set a target price of $75.0 on 07/08/2025
- Ramsey El-Assal from Barclays set a target price of $80.0 on 06/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
